Monopar Therapeutics Inc. (MNPR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Monopar Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -35.28x | -16.15x | -2.94x | -14.33x | -21.99x | -53.19x |
| P/B Ratio | 0.00x | 4.57x | 4.41x | 14.94x | 10.57x | 21.37x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 51.35x | 11.47x | 4.17x | 4.21x | 12.98x | 14.28x |
| Quick Ratio | 51.35x | 11.47x | 4.17x | 4.21x | 12.98x | 14.28x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..